What is the target price for curis?
Their forecasts range from $15.00 to $24.00. On average, they anticipate Curis' stock price to reach $19.80 in the next year. This suggests a possible upside of 323.1% from the stock's current price. View analysts' price targets for Curis or view top-rated stocks among Wall Street analysts. Who are Curis' key executives?
Should you buy curis (Cris) stock on Hammer charts?
Investors need to pay close attention to Curis (CRIS) stock based on the movements in the options market lately. Curis (CRIS) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart.
Who owns curis stock?
Curis' stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include JPMorgan Chase & Co. (0.22%). Company insiders that own Curis stock include Ali PhD Fattaey, James R Mcnab and Marc Rubin. View Institutional Ownership Trends for Curis.
Is Cirrus Logic stock headed to $86?
Cirrus Logic stock price target raised to $86 from $78 at Susquehanna Aug. 4, 2020 at 6:28 a.m. ETby Tomi Kilgore Opinion Chip stocks are flying high, yet Wall Street still sees bargains
Should I buy or sell Curis stock right now?
4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Curis in the last twelve months. There are currently 1 hold ratin...
What is Curis' stock price forecast for 2022?
4 brokerages have issued twelve-month price objectives for Curis' shares. Their forecasts range from $4.00 to $20.00. On average, they predict Curi...
How has Curis' stock performed in 2022?
Curis' stock was trading at $4.76 at the start of the year. Since then, CRIS stock has decreased by 80.0% and is now trading at $0.95. View the be...
When is Curis' next earnings date?
Curis is scheduled to release its next quarterly earnings announcement on Tuesday, August 2nd 2022. View our earnings forecast for Curis .
How were Curis' earnings last quarter?
Curis, Inc. (NASDAQ:CRIS) posted its quarterly earnings results on Thursday, May, 5th. The biotechnology company reported ($0.18) earnings per shar...
When did Curis' stock split? How did Curis' stock split work?
Curis shares reverse split on Wednesday, May 30th 2018. The 1-5 reverse split was announced on Tuesday, May 22nd 2018. The number of shares owned b...
Who are Curis' key executives?
Curis' management team includes the following people: Mr. James E. Dentzer , Pres, CEO & Director (Age 55, Pay $990.03k) ( LinkedIn Profile ) Mr...
Who are some of Curis' key competitors?
Some companies that are related to Curis include Amgen (AMGN) , Gilead Sciences (GILD) , Vertex Pharmaceuticals (VRTX) , Regeneron Pharmaceutic...
What other stocks do shareholders of Curis own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Curis investors own include Rite Aid (RAD) , Celldex Ther...
Recently Viewed Tickers
Curis Inc
Visit a quote page and your recently viewed tickers will be displayed here.
What is Curis Inc?
Curis, Inc. engages in the development and commercialization of drug candidates for the treatment of human cancers. Its pipeline includes CUDC-907, CA-4948, CA-170 and CA-327. The CUDC-907 pipeline is an orally available small molecule inhibitor of HDAC and PI3K enzymes.
What is market cap?
Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
Does market cap include convertible securities?
Market Cap (Capitalization) is a measure of the estimated value of the common equity securities of the company or their equivalent. It does not include securities convertible into the common equity securities. "Market Cap" is derived from the last sale price for the displayed class of listed securities and the total number of shares outstanding for both listed and unlisted securities (as applicable). NASDAQ does not use this value to determine compliance with the listing requirements.
How many shares of Curis stock are there after the split?
It does not include securities convertible into the common equity securities. "Market Cap" is derived from the last sale price for the displayed class of listed securities and the total number of shares outstanding for both listed and unlisted securities (as applicable).
What is the NASDAQ symbol for Curis?
An investor that had 100 shares of Curis stock prior to the reverse split would have 20 shares after the split.
How much does Curis make?
Curis trades on the NASDAQ under the ticker symbol "CRIS."
How many research reports has Curis been subject to?
How much money does Curis make? Curis has a market capitalization of $704.82 million and generates $10.84 million in revenue each year. The biotechnology company earns $-29,910,000.00 in net income (profit) each year or ($0.61) on an earnings per share basis.
What is Curis stock worth in 2020?
Curis has only been the subject of 1 research reports in the past 90 days.
What is the P/E ratio of Curis?
Curis' stock was trading at $1.09 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, CRIS shares have increased by 606.4% and is now trading at $7.70. View which stocks have been most impacted by COVID-19.
What is the average rating of Curis?
The P/E ratio of Curis is -11.11, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
